Cinnamyl-3,4-dihydroxy-α-cyanocinnamate

Overview

Cinnamyl-3,4-dihydroxy-α-cyanocinnamate ( CDC ) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate has the potential for the research of type 1 diabetes mellitus.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Lipoxygenase

Product Information

• Catalog No.: HY-138688
• CAS No.: 132465-11-3
• Molecular Formula: C19H15NO4
• Molecular Weight: 321.33
• Purity: 99.41%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (7.78 mM); Clear solution
• Availability: In-stock

Source

Original product source